Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Inovio Pharmaceuticals (INO)
- 1.190
- +0.030+2.59%
Close Apr 17 16:00 ET
- 1.200
- +0.010+0.82%
Post 17:24 ET
97.09MMarket Cap-0.66P/E (TTM)
1.200High1.160Low2.03MVolume1.160Open1.160Prev Close2.40MTurnover2.50%Turnover RatioLossP/E (Static)81.59MShares2.97952wk High4.03P/B96.69MFloat Cap1.03052wk Low--Dividend TTM81.25MShs Float2352.000Historical High--Div Yield TTM3.45%Range %1.030Historical Low1.179Avg Price1Lot Size
Inovio Pharmaceuticals (INO) Key Financial Indicators
INO Earnings per Share (EPS)
According to the latest financial report of Inovio Pharmaceuticals, the latest earnings per share (TTM) for the company is 0.31. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
INO Free Cash Flow (FCF)
Interested in knowing about Inovio Pharmaceuticals's free cash flow? The latest report shows it as -19.50M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
INO Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Inovio Pharmaceuticals shows that the company's current ratio is 1.40, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
INO Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Inovio Pharmaceuticals, the quick ratio is 1.34, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
INO Return on Equity (ROE)
Want to learn more about the financial health of Inovio Pharmaceuticals? The latest ROE figure is 45.98%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
INO Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Inovio Pharmaceuticals, the total asset return on investment (ROA) is 5.24%.
Currency: USD
Quarterly
Loading...
INO Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Inovio Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
INO Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Inovio Pharmaceuticals, the net profit margin is -30.14K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm